SonoThera

BiotechnologySeries BSouth San Francisco, USsonothera.com

Latest round

Series B

Last raised

Jun 2026

Total raised

$156M

Investors

25

About SonoThera

, operates as a biotechnology company that focuses on gene treatment using sonoporation technology. The company was co-founded by Kenneth Greenberg (CEO), and Steve Feinstein (CSO). In June 2026, SonoThera, Inc., SymBiosis Capital Management, UCB Ventures, Eli Lilly & Company, Bristol-Myers Squibb Company, Vivo Capital, Alexandria Venture Investments, Duquesne Family Office, Illumina Ventures, Johnson & Johnson Innovation, Medical Excellence Capital, RA Capital Management, F-Prime Capital, Venrock, and Vertex Ventures HC. SonoThera is a healthcare platform used to deliver payloads through a transient pore in a cell membrane. The company uses sonoporation, a microbubble-mediated biophysical process that provides gene therapy to cure diseases.

Who invested in SonoThera

25 investors across 2 rounds

See all investors in SonoThera

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 8, 2026

    Amount

    $125M

    Investors

    Locked

  2. Series A

    Apr 29, 2022

    Amount

    $30M

    Investors

    Locked

Questions about SonoThera

Who invested in SonoThera?

SonoThera has 25 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SonoThera raised?

SonoThera has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did SonoThera last raise money?

SonoThera's most recent round on record is a Series B, in Jun 2026.

What does SonoThera do?

, operates as a biotechnology company that focuses on gene treatment using sonoporation technology.

Where is SonoThera headquartered?

SonoThera is headquartered in South San Francisco, US.

Which VCs invest in companies like SonoThera?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SonoThera's stage. Their profiles are linked below.

Raising like SonoThera? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.